CAS 155405-80-4
:Methyl 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- 1H-Pyrrolo[2,3-d]pyrimidine, benzoic acid deriv.
- Methyl 4-[2-(2-Amino-4-Oxo-1,7-Dihydropyrrolo[4,5-E]Pyrimidin-5-Yl)Ethyl]Benzoate
- Methyl 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- Methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- Methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- benzoic acid, 4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-, methyl ester
- benzoic acid, 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-, methyl ester
Benzoic acid, 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-, methyl ester
CAS:Formula:C16H16N4O3Purity:98%Color and Shape:SolidMolecular weight:312.3232Methyl 4-(2-(2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-d]Pyrimidin-5-yl)Ethyl)Benzoate
CAS:Methyl 4-(2-(2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-d]Pyrimidin-5-yl)Ethyl)BenzoatePurity:99%Molecular weight:312.32g/molMethyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate
CAS:Purity:95.0%Molecular weight:312.3290100097656Methyl 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
CAS:Formula:C16H16N4O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:312.33Methyl 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
CAS:Color and Shape:NeatPemetrexed acid methyl ester
CAS:Controlled ProductApplications An intermediate in the preparation of Pemetrexed Disodium (P219500) and its derivatives as anticancer agents.
References Min, T. et al.: Med. Chem. Res., 18, 495 (2009); Ma, Y. et al.: Zhong. Xin. Zaz., 16, 134 (2007);Formula:C16H16N4O3Color and Shape:NeatMolecular weight:312.32Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate
CAS:Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate is a prodrug that is hydrolyzed to form the active drug pemetrexed disodium. The drug has been shown to be effective for the treatment of cancer and has been used in clinical trials for patients with lung cancer. The conversion of this prodrug to its active form occurs through a hydrolysis reaction at high temperature and by saponification with sodium hydroxide. Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3 - d]pyrimidin -5 -yl)ethyl)benzoate can also be converted into its active form by enzymatic action using ester
Purity:Min. 95%







